错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Management of Esophageal Cancer with Head and Neck Cancer

  • Banu Atalay Erdogan

摘要

Synchronous cancer means to the simultaneous occurrence of both types of cancer in the same patient, while metachronous cancer means that two types of cancer occur in the same patient at different times. Patients with a history of esophageal cancer are at an increased risk of developing head and neck cancer. This is likely due to shared risk factors, such as tobacco and alcohol use, and poor nutrition. In addition, some studies have suggested that there may be a genetic predisposition to the development of both types of cancer. The diagnosis and treatment of esophageal cancer with synchronous and metachronous head and neck cancer can be challenging, as the two types of cancer may require different treatment approaches. In some cases, surgery may be the best option for treating both cancers, while in other cases, a combination of surgery, radiation therapy, and chemotherapy may be required. Surgical intervention for double cancers of the head and neck and esophagus is a complex and invasive procedure that carries a high risk of complications. Some of the most common complications associated with the surgery include wound infections, tracheal tears, and necrosis, as well as stomal stenosis, empyema thoracis, cutaneous fistula, pulmonary edema, atelectasis, gastric necrosis and leakage, and gastric outlet obstruction. It is important for patients with a history of esophageal cancer or head and neck cancer to undergo regular screening and follow-up to detect any new or recurrent cancers early. This may involve regular endoscopies, computerized tomography (CT), or magnetic resonance imaging (MRI) as well as regular visits with a multidisciplinary team of healthcare providers. Overall, the management of esophageal cancer with synchronous and metachronous head and neck cancer requires a coordinated and individualized approach, considering the patient’s overall health, the extent and location of the cancers, and the potential risks and benefits of different treatment options.